The Lustgarten Foundation is the largest private funder of the world’s preeminent pancreatic cancer researchers.
To date, we have funded more than $250 million in research grants and been a leading force in every major advancement in pancreatic cancer research.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
This is it! Our year-end summary of how research, led by Lustgarten, is transforming pancreatic cancer into a curable disease. Join Lustgarten CEO Linda Tantawi and Andrew Rakeman, Vice President of Research, for an in-depth analysis with David Tuveson and Elizabeth Jaffee. Join us on THURSDAY, DECEMBER 8
WOODBURY, N.Y., Dec 06, 2022 — The Lustgarten Foundation announced the awarding of grants to Alison Klein, Ph.D., M.H.S., Co-Leader, Cancer Prevention and Control Program (CPC) Professor of Oncology at Johns Hopkins University School of Medicine for her study Identifying high-risk pancreatic cancer genes using Long Read Sequencing and Laura Wood, M.D., Ph.D., Associate Professor […]
Welcome to Lustgarten LIVE; our live-streamed webinar series created to introduce you to best-in-class experts from the field of pancreatic cancer research, technology, and science. Here, you will find registration links for upcoming webinars and recordings of past ones.
News From Lustgarten
The purpose of this study is to see if adding the investigational drug NIS793 to standard chemotherapy is more effective than standard chemotherapy alone when given as initial treatment to people with metastatic pancreatic cancer.
An international team of researchers has uncovered a new mechanism that enables cancer cells to move throughout the body, providing a potential new target to stop metastasis, which is responsible for 90 per cent of cancer deaths.
An antibody that was invented at UNC Charlotte could be used to curb pancreatic cancer relapse and metastasis, a new UNC Charlotte study has found.
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.Read Susan’s Story